Agendia Planning to File IPO in 2011 | GenomeWeb

By Tony Fong

SAN FRANCISCO (GenomeWeb News) – Dutch molecular diagnostics firm Agendia plans on going public some time this year, a company official said.

At the JP Morgan Healthcare Conference in San Francisco this week, Bernhard Sixt, Agendia's president and CEO, told GenomeWeb Daily News that the company is planning an initial public offering this year, though a specific timeline and exchange has not yet been decided.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.